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Abstract
Equid herpesviruses (EHVs) threaten equine health and can cause significant economic losses to the equine
industry worldwide. Different equid herpesviruses, EHV-1, EHV-2, EHV-4 and EHV5 are regularly detected
among horse populations. In Egypt, monitoring is sporadic but EHV-1 or EHV-4 have been reported to circu-
late in the horse population. However, there is a lack of reports related to infection and health status of horses,
likely due to the absence of regular diagnostic procedures. In the current study, the circulation of four infec-
tious equid herpesviruses (EHV-1, EHV-2, EHV-4 and EHV-5) among different Arabian horse populations
and donkeys residing the same farm was monitored. Different samples were collected and DNA was extracted
and subjected to quantitative (q)-PCR to detect the four equid herpesviruses using specific primers and probes.
Antibody titres against EHV-1 and EHV-4 were tested using virus neutralization test and type-specific ELISA.
The results showed that EHV-1, EHV-2, EHV-4 and EHV-5 are endemic and can be a continuous threat for
horses in the absence of vaccination programs and frequent virus reactivation. There is an urgent need for
introduction of active regular surveillance measures to investigate the presence of different equid her-
pesviruses, and other equine viral pathogens, in various horse populations around Egypt and to establish a stan-
dardized cataloguing of equine health status.
Keywords: alphaherpesviruses, gammaherpesviruses, arabian horses, donkeys, co-infection.
Correspondence: Walid Azab, Institut f€ur Virologie, Robert von Ostertag-Haus, Zentrum f€ur Infektionsmedizin, Freie Universit€at
Berlin, Robert-von-Ostertag-Str. 7-13, 14163 Berlin, Germany. E-mail: wfazab@zedat.fu-berlin.de
Introduction
Horses are constantly exposed to equid her-
pesviruses (EHVs), because the viruses circulate in
horse populations in all countries and regions of the
world. Among the Equidae, nine herpesviruses have
been identified to date. The viruses belong to the
Alphaherpesvirinae subfamily [six viruses: equid her-
pesviruses type 1 (EHV-1), EHV-3, EHV-4, EHV-6,
EHV-8 and EHV-9] or the Gammaherpesvirinae
subfamily [three viruses; EHV-2, EHV-5 and EHV-
7] (Davison et al. 2009). Horses are the natural host
to EHV-1, EHV-2, EHV-3, EHV-4 and EHV-5,
while donkeys are the primary host of EHV-6 (also
referred to as asinine herpesvirus 1, AsHV-1), EHV-
7 (AsHV-2), and EHV-8 (AsHV-3). EHV-9, the
newest member of the equid herpesviruses, was first
isolated from an infected Thomson gazelle; however,
recent studies suggested that zebras or other perisso-
dactyls such as the rhinoceros could be the definitive
host for this virus (Fukushi et al. 1997; Abdelgawad
et al. 2015, 2016).
EHV-1 and its close relative, EHV-4, cause signifi-
cant economic losses to the equine industry due to
clinical illnesses, which are associated with lost time
for training and performance (Allen & Bryans 1986;
Patel & Heldens 2005). Although both viruses cause
respiratory disease, only infection with EHV-1 may1Equally contributed.
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result in abortion, perinatal mortality and neurologi-
cal disorders with clinical signs that vary in severity
but can result in complete paralysis (Patel & Heldens
2005). Infection of horses with either of the two
viruses is clinically and serologically difficult to dis-
tinguish because of their high genetic and antigenic
similarity. Primary infection with either EHV-1 or
EHV-4 occurs mainly via direct horse-to-horse con-
tact. Direct contact with EHV-1-infected aborted
fetuses, placental tissues or fomites contaminated by
respiratory secretions may serve as a source of infec-
tion although the viruses are reported to be relatively
short-lived in the environment (Reed & Toribio
2004; Harless & Pusterla 2006). However, it was
shown that EHV-1 can remain stable and infectious
for over a week and up to 3 weeks in water under
different conditions of salinity, pH, temperature and
turbidity in controlled in vitro experiments (Day-
aram et al. 2017).
EHV-2 and EHV-5 are slow growing cell-associ-
ated gammaherpesviruses. Both viruses are wide-
spread in the equine population worldwide
(Borchers et al. 2006; Hue et al. 2014). EHV-2 has
been reported to be associated with upper respira-
tory tract disease, lymphadenopathy, immunosup-
pression, keratoconjunctivitis, general malaise and
poor performance (Borchers et al. 2006). EHV-5 in
contrast has been reported to be associated with pul-
monary fibrosis in horses (Williams et al. 2007).
Equine herpesviruses, like all herpesviruses, enter a
latent state but reactivation from latency may result
in recurring disease, which is accompanied by virus
shedding and transmission to other horses (Allen &
Bryans 1986; Edington et al. 1994; Crabb & Studdert
1995).
Standard diagnostic methods for EHV-1 and
related viruses are well-established, including virus
isolation and serological assays, particularly virus
neutralization tests (VNT) and type-specific ELISA
assays (Crabb & Studdert 1993; Crabb et al. 1995;
Lang et al. 2013; OIE, 2018). Quantitative PCR
(qPCR) methods offer alternatives to virus isolation
and have been proven sensitive and time-effective
(Pusterla et al. 2005).
Currently there are different inactivated or modi-
fied live EHV-1 and EHV-4 vaccines commercially
available. However, they cannot completely block
virus infection and most vaccines only induce reliable
protection against respiratory disease (Heldens et al.
2001; Patel & Heldens 2005; Ma et al. 2013). Possible
protection against neurological disease under experi-
mental conditions (Goodman et al. 2006) and abor-
tion under field conditions using EHV-1-based
vaccines (Bresgen et al. 2012) was reported.
In Egypt, there are more than 1.5 million equids,
with horses representing around 40% of the total
equine population (Animal Wealth development sec-
tor, Egyptian Ministry of Agriculture, 2010 http://
www.agr-egypt.gov.e.g/Uploads/Studies/d14ee0cb-
c15d-4fb9-9f2d-008f5b7ef873.pdf). These horses
include pure-bred registered Egyptian Arabian
horses and are mainly used for showcasing, semen
collection, and export. Although there are no defini-
tive statistics, horses play an important role in Egyp-
tian economics. This includes the direct economic
impact of the horse industry (breeding, employment
and education) and the indirect impact (related to
horse activities like organization of social events).
Currently, there is no accurate or official documenta-
tion on the health status of horses or vaccination pro-
grams. Recently, one study in Egypt detected EHV-
1, EHV-2 and EHV-4 DNA in clinical samples col-
lected from horses from 2005 to 2006 (Amer et al.
2011). Furthermore, isolation of EHV-1 from
aborted fetuses in Egypt was documented (Soliman
et al. 2008; Abd El-Hafeiz et al. 2010). In general,
lack of proper monitoring of equine infectious dis-
eases in Egypt could threaten the stability of the
horse industry in Egypt and beyond due to interna-
tional trade in horses. The aim of the current study
was to investigate the circulation of different equid
herpesviruses, particularly EHV-1, EHV-4, EHV-2




Samples were collected from Arabian horses
(n = 176) and donkeys (n = 16) from different parts
of Egypt, including the main provinces of the North
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Egypt (Cairo, Alexandria, Giza, Sharkia, Gharbia
and Monufia; Table 1 and Data S1). The Arabian
horses were used mainly for show purposes and don-
keys were used as work and draft animals. The sam-
ples were collected either at horse farms or from
horses admitted to horse clinics. Tissue samples and
placentae (placenta: n = 23 and tissues from aborted
fetuses: n = 17; total cases of abortion = 40) were
collected from aborted fetuses and mares immedi-
ately after abortion. Thirteen nasal swabs (Egyptian
Company for Medical Equipment) were collected
from horses suffering from fever and respiratory dis-
orders using sterile swabs. The swabs were placed
directly in virus transport medium (serum-free MEM
with 1% penicillin streptomycin, 1% gentamicin, and
0.1% fungizone). Cerebrospinal fluids (CSF; n = 4)
were collected from stallions suffering from neuro-
logical disorders (Table 1 and Data S1). Whole
blood collected into tubes with EDTA anticoagulant
(n = 135) and without anticoagulant, to obtain
serum, (n = 110) was obtained from apparently
healthy horses and with no history of previous vacci-
nation. After collection, all samples were packed in
coolers with ice packs and transported immediately
to the laboratory for analysis.
DNA extraction and PCR
Viral DNA was extracted from collected samples
and infected cell cultures using DNA/RNA Virus,
Tissue or Blood Mini Kits (Stratec Biomedical,
Birkenfeld, Germany) according to the manufac-
turer’s instructions.
PCR reactions were performed using the extracted
DNA as a template. Nested PCR amplifications
using degenerate PCR primers (Table 2) that specifi-
cally amplify a 250-bp fragment of herpesvirus DNA
polymerase gene were performed on all samples as
described previously (VanDevanter et al. 1996).
Fourteen randomly selected amplicons were purified
and directly sequenced by Sanger sequencing (LGC
Genomics) to confirm that the amplified fragments
contain herpesvirus DNA. All DNA samples were
re-analysed by qPCR with the Applied Biosystems
7500 FAST (ABI, Foster City, CA) using specific pri-
mers and probes targeting the highly conserved gB
gene (Table 2) (Dynon et al. 2001; Pusterla et al.
2005; Hussey et al. 2006; Dunowska et al. 2011). Pos-
itive (virus-infected cell culture) and negative (wa-
ter) controls were included from the beginning of the
extraction procedure until the reading of the results.
EHV-specific primers (Table 2) that target various
regions of two genes, gB (glycoprotein B; ORF33),
and/or POL (DNA polymerase; ORF30), were
designed and employed to amplify the corresponding
fragments. The amplified products were purified,
sequenced by Sanger sequencing (LGC Genomics),
and submitted to GenBank (accession numbers:
MG732975- MG732978).
Cells
Equine dermal (ED) cells were grown in DMEM
medium (PAN Biotech, Aidenbach, Germany) sup-
plemented with 10% fetal bovine serum (FBS; PAN
Biotech) and 100 U ml1 penicillin (Roth, Karlsruhe,
Germany) and 100 lg ml1 streptomycin (Alfa
Aesar, Kandel, Germany) in a 37°C incubator with
5% CO2 atmosphere. Cells were grown to confluency
in a 100 mm tissue culture dish, washed with phos-
phate buffer saline (PBS), trypsinized with 0.25%
trypsin supplemented with 2.5 lmol L1 EDTA and
counted in a Neubauer counting chamber.
Virus neutralization test
Virus neutralization test (VNT) was performed
according to the OIE Manual of Diagnostic Tests
and Vaccines for Terrestrial Animals (OIE, 2018).
Briefly, serum samples were inactivated at 56°C for
30 min. In 96-well plates, serial twofold dilutions of
inactivated serum were incubated with 100 plaque
forming units (PFU)/100 ll of either EHV-1 or
EHV-4 at 37°C. After 1 h, a total of 5 9 105 equine
dermal cells (ED) were added and plates were incu-
bated for 2 h at 37°C. The monolayers were overlaid
with 1.6% methylcellulose medium and plates were
incubated at 37°C for 3 days. The reaction was
stopped with 3% formalin and the plaques were
stained with Giemsa. EHV-1- and EHV-4-positive
horse serum and fetal calf serum were included as
positive and negative controls, respectively.
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Antibody titres were expressed as the reciprocal of
the highest serum dilution that protected the cells
from infection in each well. A reciprocal titre of
greater than or equal to 4 was considered positive
(Lang et al. 2013). Each test was validated with the
positive and negative sera controls.
Peptide-based ELISA
The ELISA test was carried out as described before
(Lang et al. 2013) with few modifications. Briefly,
96-well plates were coated with 1 lg ml1 strepta-
vidin (100 ll well1 dissolved in 50 nmol L1 car-
bonate-biocarbonate buffer; pH 9.6) overnight at
4°C. The wells were washed three times with PBS
containing 0.1% Tween 20 (PBST). After coating
with 100 ll well1 of the respective biotinylated
peptide [EHV-1 E (E1) peptide: KQPQPRLRVKT-
PPPVTVP and EHV-4G (G4) peptide: TEGMKN-
NPVYSESLMLNV; 2 lg ml1 in 50 nmol L1
carbonate-biocarbonate buffer], the plates were
incubated at 37°C for 2 h. The plates were then
blocked with 1% goat serum diluted in PBST and
incubated for 1 h at 37°C. After washing, serum
samples (100 ll well1 in 1:400 dilution) were added
and plates were incubated for 1 h at 37°C. Purified
goat anti-horse IgG conjugated with horseradish
peroxidase (1:20 000; Dianova, Hamburg, Germany)
was added and plates were incubated for 1 h. After
washing, binding was detected by addition of 100 ll
well1 TMB [3,3,5,5-tetramethylbenzidine, dissolved
in 42 lg ml1 citric acid, 0.01% H2O2 (pH 3.95)].
The reaction was stopped after 10 min with 100 ll
ml1 of 1 mol L1 sulphuric acid and the plates
were read at a wavelength of 450 nm on a spec-
trophotometer (TriStar LB 941, Berthold Technolo-
gies, Bad Wildbad, Germany). Based on our
previous publication (Lang et al. 2013), we have set
a cut-off value (OD value = 0.118) above which a
sample was considered positive. Samples that pro-
duced OD values between 0.118 and 0.100 were con-
sidered questionable, and samples with OD values
of <0.100 were considered negative. The same cut-
off values were used for both EHV-1 and EHV-4
ELISA. Each serum sample was tested for EHV-1
and EHV-4 antibody two independent times. Nega-
tive and positive serum controls were included in
each plate.
Table 1. List of samples used in this study
Samples* Number
of samples
History Sex Age range/
median (year)
Location
Animals with clinical problems
Aborted fetus tissues and
placenta
40† Abortion and still birth F: 40‡ 5–12/7 Cairo, Alexandria,
Giza, Sharkia, Monufia




2–12/5 Sharkia, Giza, Gharbia
Cerebrospinal fluid 4 Ataxia and hind limb paralysis M: 4 3–8/4.5 Giza, Alexandria
Total 57
Apparently healthy animals
Whole blood 135 No obvious clinical signs M: 67
F: 68







Serum 110 No obvious clinical signs M: 53
F: 57
2–12/7 Gharbia, Giza, Alexandria,
Sharkia
*Samples were collected in 2015 and 2016. †Placenta: n = 23; tissues from aborted fetuses: n = 17. ‡Numbers indicate the number of tested
animals of each sex.
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Statistical analysis
Statistical analyses and graphs of the serology
data were performed using GraphPad Prism ver-
sion 5.0 software (GraphPad Software, San Diego,
CA). Fisher’s exact test was used to compare the
frequencies or proportions of EHV-1 and EHV-4
positive samples. Differences were considered sta-
tistically significant when the P value was less
than 0.05.
Results
Detection of different equid herpesviruses
Using consensus herpesvirus PCR, a 250-bp frag-
ment was amplified in 110/192 (57%) samples. Using
virus-specific qPCR, 133/192 (69%) samples were
positive for at least one of the four EHVs. The num-
ber of samples detected by both assays was n = 64
for EHV-1, n = 5 for EHV-4, n = 63 for EHV-2 and
Table 2. Primers and probes used in the study
Product Primer Sequence Fragment References
All herpesviruses
Pan herpesvirus DFA (For) GAYTTYGCNAGYYTNTAYCC* 700 bp VanDevanter








glycoprotein B (gB) For 61722-CACTTCCATGTCAACGCACT-61741 869 bp Designed for
this studyRev 62591-TCGACTTTCTTCTCGGTCCA-62572
DNA polymerase (POL) For 54885-ACCTCCGGAGGCAAAGTTCA-54904 709 bp
Rev 54195-TTCGCCCCGTTGAGCGACAC-54214
EHV-4†
gB For 61314-CATGTCTAAAGACTCGACAT-61333 1369 bp Designed for
this studyRev 62664-GATTGGTATTATGGTTTGCG-62683
POL For 54660-CATCACAGTACACTTTTGGG-54679 843 bp
Rev 53836-ACTATAAGCTACTGTGTTTT-53855
EHV-2†
POL For 36400-GCGCGTGTTGCGCGAGTACT-36419 1270 bp Designed for
this studyRev 37651-GGTGCAGGCACAGCCTGTCT-37670
EHV-5†
POL For 32972-AAGGGTTTTGAAACAATACA-32991 1115 bp Designed for
this studyRev 34068-GAACTTTCCTTGTTGCCCGA-34087
qPCR
EHV-1 gB For CATACGTCCCTGTCCGACAGAT Hussey et al.
(2006)Rev GGTACTCGGCCTTTGACGAA
Probe 6FAM-TGAGACCGAAGATCTCCTCCACCGA-BHQ1
EHV-4 gB For CGCAGAGGATGGAGACTTTTACA Pusterla et al.
(2005)Rev CATGACCGTGGGGGTTCAA
Probe 6FAM-CTGCCCGCCGCCTACTGGATC-TAMRA
EHV-2 gB For AGGACTACTACTATGTCAG Dunowska
et al. (2011)Rev ATGGTCTCGATGTCAAACAC
Probe 6FAM-TGACATACCCACCCTACACACCATGA-
BHQ1
EHV-5 gB For ATGAACCTGACAGATGTGCC Dynon et al.
(2001)Rev CACGTTCACTATCACGTCGC
Probe 6FAM-TCCATCCACGATGGCAGGGA-BHQ1
*Bold letters indicate amino acid residues included in the primers. †Numbers before and after primer sequences represent their positions in
the genome.
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n = 37 for EHV-5. The number of samples detected
only by virus-specific qPCR was EHV-1 (n = 21),
EHV-4 (n = 4), EHV-2 (n = 10) and EHV-5 (n = 8).
Four samples were detected only by consensus her-
pesvirus PCR (Data S1). The 250-bp fragment of 14
amplicons were sequenced and the data revealed 95-
100% identity at the nucleotide level to previously
reported EHV-1 (n = 5), EHV-4 (n = 1), EHV-2
(n = 7) and EHV-5 (n = 1) DNA polymerase
sequences.
Using specific qPCR protocols, we found that the
most prevalent virus was EHV-1 (85/192; 44%), fol-
lowed by EHV-2 (73/192; 38%), EHV-5 (45/192;
23%) and EHV-4 (9/192; 4%). Among the 40 tested
samples collected from aborted cases, EHV-1 and
EHV-2 were detected in 29/40 (72%) and 16/40
(40%) samples, respectively (Table 3). EHV-4 (4/40;
10%) and EHV-5 (1/40; 2.5%) were also detected.
All four herpesviruses (mainly EHV-1 and EHV-5)
were detected in donkeys that were present at the
same farm as positive horses (Table 3). No her-
pesviruses were detected in the CSF samples. Co-in-
fections with different herpesviruses were common,
especially for EHV-1 and EHV-2 or EHV-2 and
EHV-5 (Table 4). Triple co-infections were also
detected for all viruses; however, we did not identify
coinfection with all four viruses in a single animal
(Table 4).
Four sequences, Egy-01 (EHV-1 gB sequence;
GenBank: MG732975), Egy-02 (EHV-1 POL
sequence; GenBank: MG732976), Egy-03 (EHV-2
gB; GenBank: MG732977), and Egy-04 (EHV-5 gB;
GenBank: MG732978), were obtained from the iso-
lated DNA and blasted against available EHV-se-
quences from GenBank.
Detection of EHV-1 and EHV-4 neutralizing
antibodies
Of 110 tested serum samples, 59 (54%) and 78
(71%) were seropositive by VNT for EHV-1 and
EHV-4 antibodies, respectively (Fig. 1a and Data
S1). In horse serum samples (n = 103), 54 (52%) and
75 (73%) tested positive for EHV-1 and EHV-4 anti-
bodies, respectively. In samples collected from don-
keys living in the same farm (n = 7), 5 (71%) and 3
(43%) tested positive for EHV-1 and EHV-4 anti-
bodies, respectively (Data S1). The highest neutraliz-
ing titre was 128 (Data S1). It is worth mentioning
that the horse with this high titre was apparently
healthy and positive only for EHV-5 DNA by qPCR.
The prevalence of EHV-4 antibodies in the tested
serum samples was significantly higher than that of
EHV-1 (P = 0.01; Fisher’s exact test).
Table 3. qPCR results from different samples
Samples Total EHV-1 EHV-4 EHV-2 EHV-5
Clinical problem* 57 38 4 25 6
Apparently healthy 135 47 5 48 39
Total 192 85 9 73 45
Tissue 40 29 4 16 1
Whole blood† 135 47 5 48 39
Nasal swabs 13 9 0 9 5
CSF 4 0 0 0 0
Total 192 85 9 73 45
Horses 176 77 8 71 39
Donkeys 16 8 1 2 6
Total 192 85 9 73 45
*Clinical problems included abortion, respiratory disease and ner-
vous disorders (see Table 1 and Data S1). †Whole blood was col-
lected from apparently healthy animals.









EHV-1 only 32 3
EHV-4 only 0 0
EHV-2 only 21 0
EHV-5 only 9 3
Double
detection
EHV-1 and EHV-4 4 0
EHV-1 and EHV-2 24 2
EHV-1 and EHV-5 4 2

















*This includes virus detection in samples collected from clinically
affected and apparently healthy animals.
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Discrimination between EHV-1- and EHV-4-
specific antibodies by peptide-based ELISA
EHV-1 gE (EHV-1_E)- and EHV-4 gG (EHV-
4_G)-specific peptides were used to differentiate
between EHV-1- and EHV-4-specific antibodies as
described before (Lang et al. 2013). In total, 67/110
(61%) samples tested positive for EHV-1 antibodies
and 109/110 (99%) samples for EHV-4 antibodies,
including seven donkeys that were all positive for
both EHV-1 and EHV-4 antibodies (Fig. 1b and
Data S1). Ten additional samples were classified as
questionable for EHV-1 antibodies (Data S1). The
data showed that the prevalence of EHV-4 antibod-
ies was significantly higher than that of EHV-1
(P < 0.0001; Fisher’s exact test).
There were 14/59 (24%) horse serum samples that
tested positive for EHV-1 antibodies by VNT, were
negative by EHV-1 ELISA (Data S1). In addition,
there were 8 and 31 samples that were negative by
VNT and tested positive with EHV-1 and EHV-4
ELISA, respectively (Data S1). The data showed
that ELISA was significantly more sensitive for
EHV-4, but not EHV-1, antibodies (Fig. 1c,d;
P < 0.0001; Fisher’s exact test).
Discussion
The loss of valuable horses and revenue from major
horse events has negative consequences for the horse
breeding and sports industry. In Egypt, few monitor-
ing studies have been performed but the existence of
equine herpesviruses, particularly EHV-1 and EHV-
4, in the horse population has been documented
(Abd El-Hafeiz et al. 2010; Amer et al. 2011; Al-
Shammari et al. 2016; Fararh et al. 2016). Egyptian
Arabian horses are an important part of the coun-
try’s economy due to global trade linked to the inter-
national reputation of the Egyptian breeding lines.
In the current study, we investigated the circulation
of equine alpha- and gammaherpesviruses among
Arabian horses and donkeys in Egypt.
A total of 192 samples were collected from appar-
ently healthy animals or horses with clinical signs of
Fig. 1. Detection of EHV-1 and EHV-4 antibodies. Number of ani-
mals (n = 110) positive or negative for the presence of specific anti-
bodies either by virus neutralization test (a) or peptide-specific ELISA
(b). The prevalence of EHV-4 antibodies was significantly higher in
the serum samples tested by virus neutralization test (VNT) or ELISA
(Fisher’s exact test). Number of animals positive or negative for the
presence of EHV-1-specific (c) or EHV-4-specific (d) antibodies using
ELISA and VNT. The number of animals tested positive for EHV-4
antibodies by ELISA was significantly (Fisher’s exact test) higher than
this tested by VNT.
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abortion, respiratory disease or neurological disor-
ders. EHV-1 and EHV-2, respectively, were the
main viruses detected in clinically affected horses;
however, EHV-4 and EHV-5 were also detected to a
lesser extent. It is difficult to state whether any of
these viruses were responsible for the clinical dis-
eases among horses sampled due to the absence of
clear case history and proper diagnosis at the time of
disease onset. On the other hand, EHV-2, EHV-1
and EHV-5, respectively, were mostly detected in
the apparently healthy horses. Interestingly, all
viruses, but predominantly EHV-1 and EHV-5, were
detected in the tested donkey samples. Our data as
well as previous studies clearly indicate that these
equine herpesviruses are circulating in equid popula-
tions in Egypt (Abd El-Hafeiz et al. 2010; Amer
et al. 2011; Al-Shammari et al. 2016; Mohamed et al.
2017). The frequency of detection of each virus
among equids varied between studies. This can be
explained by the age, health status and breed of
horses as well as geographical variability and envi-
ronmental factors. Detection of EHV in donkeys (in
this study) and mules (Mohamed et al. 2017) is inter-
esting but it is not clear if the donkeys contracted the
infection from horses or whether they can play a role
in further spreading of the infection.
Co-infections with up to three viruses were
detected in both clinically infected and apparently
healthy horses and donkeys. This dual infection was
reported before in horses but also in wild equids
(Amer et al. 2011; Back et al. 2015; Abdelgawad et al.
2016; Laabassi et al. 2017; Negussie et al. 2017). How-
ever, their potential synergistic effect on the disease
outcome remains to be elucidated. The detection of
EHV-1, associated with other EHVs in donkeys, pro-
vides hallmarks on the potential source of infection.
Furthermore, donkeys in Egypt are always stressed
due to the assigned hard work, which might increase
the probability of EHV shedding after reactivation.
It was clear that both EHV-2- and EHV-5 are cir-
culating among apparently healthy horses (Table 3).
This high prevalence may increase the risk of other
possible infections due to compromising horse immu-
nity (Nordengrahn et al. 1996; Negussie et al. 2017).
Further studies are needed to better understand the
clinical outcomes of EHV-2 and EHV-5. The role of
EHV-4 in disease outcome cannot be ideally
assessed due to the low number of detected positive
samples.
Serological analysis was conducted for all col-
lected serum samples. Although VNT is known to
be an efficient and robust test, it cannot accurately
discriminate between antigenically similar viruses,
like EHV-1 and EHV-4 (Crabb et al. 1995; Lang
et al. 2013); this was further confirmed in our cur-
rent data. We found that 14 of 59 horse serum
samples, which tested positive for EHV-1 antibod-
ies by VNT, were negative by EHV-1 ELISA but
positive by EHV-4 ELISA. This result indicates
that the detected EHV-1 neutralizing antibodies
were a result of cross-reactivity with EHV-4. In
addition, there was a clear difference in sensitivity
when comparing VNT with ELISA (Fig. 1c,d). In
general, our data clearly support the previous data
indicating that peptide-ELISA is considered a
specific and sensitive serological test for detection
of EHV-1 and EHV-4 seroprevalence (Lang et al.
2013; Damiani et al. 2014). VNT and specific pep-
tide-based ELISA demonstrated that the preva-
lence of EHV-4 antibodies among sampled horses
was significantly higher than that of EHV-1. These
results strongly suggest that EHV-4 is omnipresent
in horse population in Egypt and that most of the
horses probably contracted the infection during
their early life.
Equid herpesviruses EHV-1, EHV-4, EHV-2 and
EHV-5 circulate among various Arabian horse popu-
lations in Egypt. In the present study, all viruses
were detected in apparently healthy and clinically ill
equids. Although Arabian horses are considered one
of the most proficient and valuable breeds used in
breeding, show competitions and exportation, no
regular monitoring programs are performed to track
the health status of these animals, including EHV
infections. In addition, vaccination programs against
equid herpesviruses, that might reduce the risk of
infection, are not routinely performed by veterinary
practitioners in Egypt. In the current study, we shed
light on the frequency of detection of various equine
herpesviruses among sampled population(s) of Ara-
bian horses in Egypt. These data will help to guide
efficient diagnosis and preventive measures against
© 2019 The Authors. Veterinary Medicine and Science Published by John Wiley & Sons Ltd.
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these viruses through establishing regular testing
(molecular and serological) and vaccination pro-
grams.
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